Cocaine-Related Disorders
162
0
0
128
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
16 trials with published results (10%)
Research Maturity
128 completed trials (79% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.6%
9 terminated out of 162 trials
93.4%
+6.9% vs benchmark
7%
12 trials in Phase 3/4
13%
16 of 128 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 128 completed trials
Clinical Trials (162)
Neurocircuit Strategy to Decrease Cocaine Cue Reactivity
Psilocybin-facilitated Treatment for Cocaine Use
Targeting Anhedonia in Cocaine Use Disorder
The Role of Neuroactive Steroids in Stress, Drug Craving and Drug Use in Cocaine Use Disorders
Quetiapine for Cocaine Use and Cravings
Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study
Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention
Computerized Exercise to Alter Stimulant Approach Responses
Open Label Pharmaco- Magnetic Resonance Spectrography (MRS) Study of Clavulanic Acid
Progesterone for the Treatment of Cocaine Dependence - 1
Brain Mechanisms in Young Adults
Lorcaserin in the Treatment of Cocaine Use Disorder
Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence
Treatment With Transcranial Magnetic Stimulation for Cocaine Addiction: Clinical Response and Functional Connectivity.
Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1
Dopamine Reuptake Inhibitors of Cocaine Abuse - 1
Mazindol for Cocaine Abuse - 2
Disulfiram for Cocaine-Alcohol Abuse - 3
Phase I Functional Magnetic Resonance Imaging (fMRI) Pharmacodynamic Studies of Compounds for Opioid Use Disorder and Cocaine Use Disorder
Use of Intranasal Oxytocin During Detoxification of Crack Cocaine